CPC A61K 31/198 (2013.01) [A23L 33/12 (2016.08); A23L 33/13 (2016.08); A23L 33/14 (2016.08); A23L 33/155 (2016.08); A23L 33/175 (2016.08); A23L 33/30 (2016.08); A61K 9/0053 (2013.01); A61K 9/0095 (2013.01); A61K 31/07 (2013.01); A61K 31/202 (2013.01); A61K 31/70 (2013.01); A61K 31/7088 (2013.01); A23V 2002/00 (2013.01)] | 9 Claims |
1. A method of treating or preventing cachexia induced by at least one of surgery, cancer or infection in a patient who is an individual with bladder cancer scheduled to undergo a radical cystoprostatectomy, the method comprising administering to the patient a specialized immunonutrition supplement comprising a combination of L-arginine, omega-3 fatty acids, vitamin A, and nucleotides, and
the specialized immunonutrition supplement is administered to the patient in a daily dose that provides an amount of the omega-3 fatty acids that comprises about 0.5 g to about 10.0 g of eicosapentaenoic acid and docosahexaenoic acid in total per day and that provides at least about 500 μg RE of the vitamin A per day; and
the specialized immunonutrition supplement is administered to the patient at least once per day for a time period extending from a pre-operative day that is three to seven days prior to the radical cystoprostatectomy to a post-operative day that is three to seven days after the radical cystoprostatectomy.
|